Stallion India Fluorochemicals Posts Record Quarterly & Half-Yearly Results; Maintains FY26 Revenue Guidance
Stallion India Fluorochemicals reported record Q2 and H1 FY25-26 results with significant revenue and profit growth, maintaining its full-year revenue guidance of ₹43,000.00 lakhs.
The announcement of record financial performance and the reaffirmation of strong revenue guidance indicate significant positive operational and financial momentum, likely to have a high impact on investor perception and stock value.
The company reported record quarterly and half-yearly results with substantial increases in revenue, EBITDA, PAT, and EPS. Management expressed confidence in achieving the full-year revenue guidance despite a challenging environment.
Stallion India Fluorochemicals Limited (SIFL) announced its unaudited financial results for Q2 and H1 FY25-26, reporting record performance and maintaining its FY26 revenue guidance. Key highlights include: * Q2 FY25-26 Performance (YoY Change): * Total Revenue: ₹10,575.75 lakhs, a 55.57% increase. * EBITDA: ₹1,576.77 lakhs, a 568.77% increase. * PAT: ₹1,141.67 lakhs, a 1,224.61% increase. * EPS: ₹1.42, a 914.29% increase. * H1 FY25-26 Performance (YoY Change): * Total Revenue: ₹21,630.31 lakhs, a 52.83% increase. * EBITDA: ₹3,013.71 lakhs, a 99.51% increase. * PAT: ₹2,178.00 lakhs, a 135.03% increase. * EPS: ₹2.73, an 80.79% increase. Mr. Shazad Rustomji, Managing Director & CEO, commented on the exceptional results, attributing the improvement to higher volumes, better product mix, and operational efficiencies. Despite a challenging business environment, the company achieved over 50% of its projected ₹43,000.00 lakhs revenue guidance for FY25-26 in the first half and remains confident in achieving the full-year guidance, anticipating seasonally stronger forthcoming quarters.
What to do with a filing like this
Stallion India Fluorochemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Stallion India Fluorochemicals Limited. Read the original for the full detail.